1 00:00:00,160 --> 00:00:07,120 Speaker 1: Bloomberg Audio Studios, podcasts, radio news. 2 00:00:10,200 --> 00:00:13,520 Speaker 2: Welcome to the Bloomberg Daybreak Asia podcast. I'm Doug Chrisener. 3 00:00:13,920 --> 00:00:17,639 Speaker 2: So US China trade talks remain our number one topic, 4 00:00:17,840 --> 00:00:21,560 Speaker 2: and today Treasury Secretary Bessett was saying that Beijing has 5 00:00:21,560 --> 00:00:25,520 Speaker 2: not threatened to cut off pharmaceutical exports to the US. 6 00:00:25,640 --> 00:00:28,400 Speaker 2: In a moment or two, we'll check in with Bloomberg 7 00:00:28,440 --> 00:00:31,800 Speaker 2: Opinion for a look at how biotech is advancing in China. 8 00:00:31,840 --> 00:00:35,000 Speaker 2: I'll be joined in a moment by Bloomberg Opinion columnist 9 00:00:35,040 --> 00:00:38,720 Speaker 2: Truly Ren in Hong Kong. Meantime, President Trump declared a 10 00:00:38,800 --> 00:00:42,000 Speaker 2: trade framework with China has been completed, and he said 11 00:00:42,040 --> 00:00:46,839 Speaker 2: Beijing will supply rare earth materials and magnets upfront. The 12 00:00:46,880 --> 00:00:50,400 Speaker 2: President also said the US will allow Chinese students into 13 00:00:50,440 --> 00:00:55,000 Speaker 2: American colleges and universities. Tariffs meantime for these two countries 14 00:00:55,040 --> 00:00:59,080 Speaker 2: will be maintained at their current lower levels, but remember 15 00:00:59,400 --> 00:01:02,400 Speaker 2: that number is still much higher than when the President 16 00:01:02,440 --> 00:01:06,480 Speaker 2: took office in January. Bloomberg's Jennifer Welsh says that Beijing 17 00:01:06,760 --> 00:01:07,919 Speaker 2: has learned some things. 18 00:01:08,400 --> 00:01:11,000 Speaker 3: China now realizes they have this major hammer in the 19 00:01:11,000 --> 00:01:14,600 Speaker 3: form of these critical mineral export controls that they can leverage, 20 00:01:14,600 --> 00:01:17,399 Speaker 3: and I think that really dilutes the US ability to 21 00:01:17,520 --> 00:01:20,080 Speaker 3: push China towards the deal that Washington says it. 22 00:01:20,040 --> 00:01:23,480 Speaker 2: Once Jennifer Welsch of Bloomberg Economics. By the way, presidents 23 00:01:23,520 --> 00:01:26,960 Speaker 2: Trump and She must still formally sign off on this agreement. 24 00:01:27,360 --> 00:01:29,520 Speaker 2: So let's take a look at the market action right now, 25 00:01:29,640 --> 00:01:32,080 Speaker 2: maybe a little bit about tariff action as well. I'm 26 00:01:32,160 --> 00:01:37,640 Speaker 2: joined by Zachary Hill, head of portfolio management at Horizon Investments. Zach, 27 00:01:37,680 --> 00:01:39,680 Speaker 2: thank you for making time to chat with us. Could 28 00:01:39,720 --> 00:01:41,720 Speaker 2: you weigh in on your reaction to what you've been 29 00:01:41,800 --> 00:01:44,640 Speaker 2: hearing about this agreement that was reached in London a 30 00:01:44,680 --> 00:01:45,520 Speaker 2: couple of days ago. 31 00:01:46,120 --> 00:01:47,680 Speaker 4: Yeah, dok. Great to be with you today. 32 00:01:48,040 --> 00:01:50,880 Speaker 1: You know, I think this agreement broadly kind of hits 33 00:01:50,920 --> 00:01:52,960 Speaker 1: on all the points, and the market was already expecting, 34 00:01:53,600 --> 00:01:57,400 Speaker 1: so it really seems like a status quo matt expectations, 35 00:01:57,440 --> 00:02:00,680 Speaker 1: but to not exceed them, and you know the context 36 00:02:00,680 --> 00:02:03,520 Speaker 1: of how much risk premium has come out of the 37 00:02:03,560 --> 00:02:06,600 Speaker 1: market over the last month and a half or two months, 38 00:02:07,240 --> 00:02:09,840 Speaker 1: you know, it wasn't enough to push equity and disease 39 00:02:09,919 --> 00:02:12,120 Speaker 1: higher today, which kind of speaks a little bit to 40 00:02:12,160 --> 00:02:15,560 Speaker 1: the fact that we're pretty fully valued here above six 41 00:02:15,600 --> 00:02:16,400 Speaker 1: thousand of the S and P. 42 00:02:16,840 --> 00:02:20,120 Speaker 2: So Zach, I'm curious about how you're navigating the current 43 00:02:20,200 --> 00:02:22,840 Speaker 2: terrain when it comes to tariffs, given what we know 44 00:02:23,000 --> 00:02:26,720 Speaker 2: so far. It's interesting today on truth Social President Trump 45 00:02:26,800 --> 00:02:29,720 Speaker 2: posted the US is getting a total of fifty five 46 00:02:29,760 --> 00:02:33,239 Speaker 2: percent tariffs, China is getting ten percent. Now, so let's 47 00:02:33,280 --> 00:02:36,000 Speaker 2: say that those levels do remain in place for a period. 48 00:02:36,440 --> 00:02:39,160 Speaker 2: How is this going to impact your decision making when 49 00:02:39,160 --> 00:02:40,640 Speaker 2: it comes to putting money to work. 50 00:02:41,360 --> 00:02:44,000 Speaker 1: Yeah, I mean those levels are pretty pretty large and 51 00:02:44,040 --> 00:02:47,320 Speaker 1: are likely going to have to be you know, force 52 00:02:47,400 --> 00:02:51,080 Speaker 1: companies to adjust in terms of their cost structure and 53 00:02:51,080 --> 00:02:54,480 Speaker 1: in the way that they're sourcing you know, inputs, and so, 54 00:02:54,919 --> 00:02:56,440 Speaker 1: you know, we do think that that's going to, you know, 55 00:02:56,520 --> 00:03:00,200 Speaker 1: weigh on economic activity. It's it's not likely large to 56 00:03:00,240 --> 00:03:03,560 Speaker 1: put us into a recession, but it is likely something 57 00:03:03,560 --> 00:03:05,840 Speaker 1: that we're going to feel a growth slow down. And 58 00:03:05,880 --> 00:03:09,680 Speaker 1: so from a positioning perspective, we're trying to keep things, 59 00:03:10,520 --> 00:03:12,800 Speaker 1: you know, pretty pretty tight and pretty close to home 60 00:03:13,360 --> 00:03:15,440 Speaker 1: and keep a little bit of dry powder because we 61 00:03:15,480 --> 00:03:18,040 Speaker 1: do think, you know, especially in the summer months after 62 00:03:18,840 --> 00:03:22,120 Speaker 1: you know, a pretty exhausting period of trading UH to 63 00:03:22,160 --> 00:03:22,840 Speaker 1: start the year. 64 00:03:22,960 --> 00:03:25,240 Speaker 4: That this low liquidity environment. 65 00:03:24,960 --> 00:03:28,359 Speaker 1: Is likely to uncover some opportunities for us to put 66 00:03:28,360 --> 00:03:29,160 Speaker 1: some capital to work. 67 00:03:29,280 --> 00:03:31,960 Speaker 2: Let's change gears. Talk a little bit about what's happening 68 00:03:31,960 --> 00:03:34,600 Speaker 2: in Washington with respect to the tax bill. I know 69 00:03:34,639 --> 00:03:37,280 Speaker 2: that the Senate is now trying to negotiate a few things, 70 00:03:37,720 --> 00:03:42,560 Speaker 2: and there is still concern about the level of deficit spending. 71 00:03:42,600 --> 00:03:45,360 Speaker 2: I guess that we could say double line capitalist. Jeff 72 00:03:45,360 --> 00:03:48,080 Speaker 2: Gunlock was saying today that America's debt burden and interest 73 00:03:48,120 --> 00:03:51,840 Speaker 2: expense have become untenable. The bond market at this point 74 00:03:51,880 --> 00:03:54,240 Speaker 2: really doesn't seem to be as upset as it was 75 00:03:54,760 --> 00:03:57,200 Speaker 2: a month ago or so it would appear when the 76 00:03:57,240 --> 00:03:59,880 Speaker 2: House was negotiating its version. How do you make sense 77 00:03:59,880 --> 00:04:00,240 Speaker 2: of that? 78 00:04:01,000 --> 00:04:02,800 Speaker 1: Yeah, I think you know, the way that we make 79 00:04:02,880 --> 00:04:06,560 Speaker 1: sense of that is just this narrative volatility we've had 80 00:04:06,600 --> 00:04:07,600 Speaker 1: on the macro front. 81 00:04:07,720 --> 00:04:09,480 Speaker 4: You know, tariffs come and go. 82 00:04:10,480 --> 00:04:12,640 Speaker 1: You know, doge was a thing that the market was 83 00:04:12,640 --> 00:04:14,400 Speaker 1: talking about for quite a long period of time, and 84 00:04:14,440 --> 00:04:17,880 Speaker 1: now it's it's no longer relevant. And the concern about 85 00:04:17,920 --> 00:04:21,080 Speaker 1: you know, budgets and the deficit bill and long term 86 00:04:21,120 --> 00:04:24,240 Speaker 1: interest rates has been something that's waxed and waned. You know, 87 00:04:24,279 --> 00:04:27,000 Speaker 1: I would agree with you with that importance in the market. 88 00:04:27,440 --> 00:04:30,320 Speaker 1: Narrative has has faded, and you know likely is not 89 00:04:30,360 --> 00:04:33,279 Speaker 1: going to come back unless we see a material upside 90 00:04:33,279 --> 00:04:36,200 Speaker 1: surprise to the deficit. So, you know, nobody really thinks 91 00:04:36,279 --> 00:04:39,040 Speaker 1: that we're going to be cutting the deficit from current levels. 92 00:04:39,760 --> 00:04:42,360 Speaker 1: If we expanded in a really material way, that might 93 00:04:43,040 --> 00:04:45,320 Speaker 1: cause them indigestion in the long end of the bond market. 94 00:04:45,360 --> 00:04:47,840 Speaker 1: But it seems like a lot of that, at least 95 00:04:47,880 --> 00:04:49,520 Speaker 1: in the near term, is already in the price and 96 00:04:49,560 --> 00:04:51,120 Speaker 1: we've seen the curves deepen pretty. 97 00:04:50,920 --> 00:04:54,120 Speaker 2: Dramatically right to we're down today across the curve. Remember 98 00:04:54,160 --> 00:04:56,640 Speaker 2: that we did have that benign reading on make consumer 99 00:04:56,680 --> 00:04:59,359 Speaker 2: prices first thing in the morning and kind of goes 100 00:04:59,440 --> 00:05:01,760 Speaker 2: to the notion that maybe we can get more than 101 00:05:01,839 --> 00:05:04,120 Speaker 2: one FED rate cut in this year. I think the 102 00:05:04,160 --> 00:05:07,599 Speaker 2: swaps market is fully pricing in twenty five basis point 103 00:05:07,600 --> 00:05:10,200 Speaker 2: cut in October and now maybe a seventy five percent 104 00:05:10,279 --> 00:05:14,000 Speaker 2: probability we get a cut in September as well. How 105 00:05:14,000 --> 00:05:16,320 Speaker 2: are you feeling about the FED as a part of 106 00:05:16,320 --> 00:05:16,880 Speaker 2: this story. 107 00:05:17,520 --> 00:05:20,120 Speaker 1: Yeah, you know, the Fed has been kind of on 108 00:05:20,160 --> 00:05:23,080 Speaker 1: the sidelines for a while because of all the uncertainty 109 00:05:23,400 --> 00:05:25,600 Speaker 1: around you know, what the economy, how the economy is 110 00:05:25,600 --> 00:05:28,559 Speaker 1: going to involve, and how inflation is going to involve. 111 00:05:28,560 --> 00:05:30,479 Speaker 1: And it's actually interesting, the you know, end of year 112 00:05:30,520 --> 00:05:34,279 Speaker 1: interest rate implied in the futures market is about the 113 00:05:34,320 --> 00:05:37,040 Speaker 1: same as it was to start the year, so about 114 00:05:37,040 --> 00:05:39,240 Speaker 1: fifty basis points worth of cuts. 115 00:05:39,640 --> 00:05:40,720 Speaker 4: And so, you know, one of the. 116 00:05:40,640 --> 00:05:43,760 Speaker 1: Things that we're watching is the potential now that we've 117 00:05:43,760 --> 00:05:46,479 Speaker 1: had a few good inflation prints in a row after 118 00:05:46,800 --> 00:05:49,279 Speaker 1: a series of bad inflation prints to end the year 119 00:05:49,320 --> 00:05:50,479 Speaker 1: and to start this year. 120 00:05:51,080 --> 00:05:53,600 Speaker 4: To see if that emboldens some of the doves. 121 00:05:53,880 --> 00:05:55,880 Speaker 1: You know, in this in this vacuum that we have 122 00:05:56,000 --> 00:05:58,600 Speaker 1: right now to start pushing for the idea that interest 123 00:05:58,680 --> 00:06:02,280 Speaker 1: rates are too high. That's not our base case scenario, 124 00:06:02,279 --> 00:06:03,719 Speaker 1: and the economy seems to be doing. 125 00:06:03,640 --> 00:06:05,520 Speaker 4: Just fine with interest rates above four percent. 126 00:06:06,240 --> 00:06:08,080 Speaker 1: But from the way the Fed looks at things, they 127 00:06:08,080 --> 00:06:10,719 Speaker 1: do still think that they need to be cutting at 128 00:06:10,720 --> 00:06:12,400 Speaker 1: some point, and so that's something that we're going to 129 00:06:12,440 --> 00:06:14,200 Speaker 1: be paying quite a bit of attention to over the 130 00:06:14,240 --> 00:06:17,760 Speaker 1: next few weeks to see if that narrative of the 131 00:06:17,800 --> 00:06:19,520 Speaker 1: FED needs to start acting, and they're not going to 132 00:06:19,560 --> 00:06:21,880 Speaker 1: act this summer because it's too soon, but they could 133 00:06:21,880 --> 00:06:24,479 Speaker 1: potentially act pretty forcefully in the fall. 134 00:06:24,560 --> 00:06:26,040 Speaker 4: And so that's something that we're going to be watching, 135 00:06:26,800 --> 00:06:28,200 Speaker 4: you know, as the news flow evolves. 136 00:06:28,480 --> 00:06:31,040 Speaker 2: So President Trump was saying that he is very very 137 00:06:31,040 --> 00:06:34,440 Speaker 2: close to releasing the name of a nominee to replace 138 00:06:34,480 --> 00:06:37,880 Speaker 2: FED shared J. Powell, and a number of market participants 139 00:06:38,160 --> 00:06:42,000 Speaker 2: we're saying the probability of Trump appointing someone that is 140 00:06:42,120 --> 00:06:45,760 Speaker 2: uber dubvish is very very high, given mister Trump's stance 141 00:06:45,839 --> 00:06:48,839 Speaker 2: on being pro growth. What would that do in your 142 00:06:48,920 --> 00:06:51,599 Speaker 2: mind if we get an uber dubbish FED chairman. 143 00:06:52,120 --> 00:06:53,720 Speaker 1: Yeah, I don't think that would be good for market 144 00:06:53,839 --> 00:06:56,359 Speaker 1: sentiment generally speaking, because it's going to cause you some 145 00:06:56,400 --> 00:06:59,800 Speaker 1: pretty material steepening in the yield curve and that's going 146 00:06:59,839 --> 00:07:03,359 Speaker 1: to be felt in equity valuations, and similar to some 147 00:07:03,440 --> 00:07:05,160 Speaker 1: of the price action that we've seen, you know at 148 00:07:05,160 --> 00:07:08,120 Speaker 1: parts of this year, you know, higher long term interest 149 00:07:08,200 --> 00:07:10,160 Speaker 1: rates that we met with a lower dollar and not 150 00:07:10,160 --> 00:07:11,160 Speaker 1: not a higher one. 151 00:07:11,200 --> 00:07:12,920 Speaker 4: As the typical relationship would hold. 152 00:07:12,960 --> 00:07:14,760 Speaker 1: And so you know, we don't think that would be 153 00:07:14,800 --> 00:07:17,760 Speaker 1: good for markets, and there's a potential, you know, like 154 00:07:17,800 --> 00:07:19,920 Speaker 1: you said that if we get an announcement you know, 155 00:07:20,080 --> 00:07:22,440 Speaker 1: more in the in the near future, we could have 156 00:07:22,840 --> 00:07:26,640 Speaker 1: that shadow fed chair idea, which is something that investors 157 00:07:26,640 --> 00:07:29,600 Speaker 1: have not ever had to deal with in the US, 158 00:07:29,640 --> 00:07:31,960 Speaker 1: and so, you know, I don't think that's something generally 159 00:07:32,000 --> 00:07:34,240 Speaker 1: speaking that would be well received by by the market. 160 00:07:34,440 --> 00:07:36,960 Speaker 2: Let's talk a little bit about the equity space right now. 161 00:07:37,040 --> 00:07:39,280 Speaker 2: Are you still constructive on US stocks? 162 00:07:40,000 --> 00:07:40,120 Speaker 4: Uh? 163 00:07:40,200 --> 00:07:42,840 Speaker 1: We are constructive on US stocks, but not nearly as much, 164 00:07:43,360 --> 00:07:46,160 Speaker 1: you know as we were to start the year. You know, actually, 165 00:07:46,200 --> 00:07:48,880 Speaker 1: our favorite in our highest conviction call that we have 166 00:07:49,680 --> 00:07:52,760 Speaker 1: is that we're likely to continued dollar weakness, especially against 167 00:07:53,800 --> 00:07:57,240 Speaker 1: you know, large uh, you know, international economies like Europe 168 00:07:57,240 --> 00:08:01,320 Speaker 1: and Japan and so, you know, markets is a part 169 00:08:01,360 --> 00:08:04,320 Speaker 1: of the global equity universe that we favor. And within 170 00:08:04,400 --> 00:08:07,640 Speaker 1: the US, you know, kind of keeping things pretty neutral 171 00:08:07,640 --> 00:08:10,600 Speaker 1: and not going on the defensive side of things, maintaining 172 00:08:10,600 --> 00:08:14,200 Speaker 1: some tech exposure and playing offense in the in the 173 00:08:14,200 --> 00:08:17,160 Speaker 1: domestic financials and the banks, as we think that's the 174 00:08:17,200 --> 00:08:20,240 Speaker 1: area of the market that has the clearest de regulatory tailwinds. 175 00:08:20,280 --> 00:08:22,640 Speaker 2: Are those the same things that you would employ if 176 00:08:22,640 --> 00:08:25,920 Speaker 2: you went offshore financials in tech, Well. 177 00:08:25,840 --> 00:08:28,280 Speaker 1: The composition of the offshore market's a good bit different, 178 00:08:28,320 --> 00:08:30,840 Speaker 1: and so you know, a lot of our you know, 179 00:08:30,920 --> 00:08:34,200 Speaker 1: favoring international markets more than we have over the last 180 00:08:34,240 --> 00:08:36,599 Speaker 1: few years is due to the dollar dynamics that we 181 00:08:36,640 --> 00:08:39,520 Speaker 1: think are can continue to be in play. You know, 182 00:08:39,559 --> 00:08:41,760 Speaker 1: the sector composition of those markets is a good bit 183 00:08:42,200 --> 00:08:43,800 Speaker 1: is a good bit different than what you get in 184 00:08:43,840 --> 00:08:46,440 Speaker 1: the US, and so we do think, especially in this 185 00:08:46,559 --> 00:08:48,880 Speaker 1: kind of environment where risk is higher than it has 186 00:08:48,920 --> 00:08:51,840 Speaker 1: been in some time, that international stocks are going to 187 00:08:51,880 --> 00:08:54,000 Speaker 1: offer a lot more diversification. 188 00:08:53,360 --> 00:08:54,400 Speaker 4: Than they have in the past. 189 00:08:54,720 --> 00:08:57,600 Speaker 1: You know, US investors have been pretty disappointed with the 190 00:08:57,600 --> 00:09:01,720 Speaker 1: benefits of global diversification really for the last ten plus years. 191 00:09:01,720 --> 00:09:04,160 Speaker 1: But we do think this is an environment where that's 192 00:09:04,160 --> 00:09:07,400 Speaker 1: going to continue to pay dividends in terms of reducing 193 00:09:08,040 --> 00:09:11,200 Speaker 1: overall portfolio risk and potentially improving returns. 194 00:09:11,320 --> 00:09:14,520 Speaker 2: I'm curious as to how you're thinking about Chinese equities 195 00:09:14,600 --> 00:09:17,040 Speaker 2: right now. Obviously, the deep seek moment was a big 196 00:09:17,080 --> 00:09:19,440 Speaker 2: one for the equity space. In a moment we're going 197 00:09:19,480 --> 00:09:21,280 Speaker 2: to be taking a look at what's going on with 198 00:09:21,320 --> 00:09:24,760 Speaker 2: biotech in China. How do you view Chinese equities. 199 00:09:25,520 --> 00:09:27,400 Speaker 1: Yeah, I mean, China is one place in terms of 200 00:09:27,440 --> 00:09:31,160 Speaker 1: equity market composition where you can actually get a lot 201 00:09:31,200 --> 00:09:34,400 Speaker 1: of high growth tech names. The problems there, you know, 202 00:09:34,520 --> 00:09:36,319 Speaker 1: are are potentially existential. 203 00:09:36,400 --> 00:09:37,440 Speaker 4: However, in terms of. 204 00:09:38,200 --> 00:09:40,360 Speaker 1: You know, the few between the US and China, which 205 00:09:40,760 --> 00:09:42,880 Speaker 1: while it seems to be on a better page today, 206 00:09:43,400 --> 00:09:44,920 Speaker 1: you know, two and a half months ago was in 207 00:09:45,040 --> 00:09:47,360 Speaker 1: it was in a very very dark place. And so 208 00:09:47,880 --> 00:09:50,600 Speaker 1: you know, we're a little bit cautious on EM as 209 00:09:50,800 --> 00:09:54,240 Speaker 1: as a whole, and we don't necessarily think that that 210 00:09:54,320 --> 00:09:56,560 Speaker 1: kind of dollar weakness trend that we expect is going 211 00:09:56,640 --> 00:10:00,480 Speaker 1: to going to extend across the EM universe more broadly, 212 00:10:00,559 --> 00:10:05,640 Speaker 1: and so, you know, not really embracing the EM trade. 213 00:10:06,120 --> 00:10:07,920 Speaker 4: We prefer develop markets. 214 00:10:08,480 --> 00:10:10,560 Speaker 2: Zach will leave it there, thank you so much. Zachary 215 00:10:10,640 --> 00:10:14,720 Speaker 2: Hill is head of portfolio management at Horizon Investments. Joining 216 00:10:14,800 --> 00:10:25,240 Speaker 2: us here on the Daybreak Asia podcast. Welcome back to 217 00:10:25,280 --> 00:10:29,400 Speaker 2: the Daybreak Asia Podcast. I'm Doug Chrisner. China has offered 218 00:10:29,559 --> 00:10:32,480 Speaker 2: a few deep seek moments so farthes here, and it 219 00:10:32,559 --> 00:10:35,959 Speaker 2: really shows the country is more than just the world's 220 00:10:36,040 --> 00:10:40,120 Speaker 2: largest factory. China has clearly demonstrated it can compete with 221 00:10:40,200 --> 00:10:43,959 Speaker 2: the US on the technology front in areas from artificial 222 00:10:44,000 --> 00:10:48,800 Speaker 2: intelligence to military defense, and now Chinese biotech is having 223 00:10:48,840 --> 00:10:51,400 Speaker 2: its day in the sun. For a closer look, I'm 224 00:10:51,440 --> 00:10:54,640 Speaker 2: joined by Bloomberg opinion columnist Julie Wren. She's on the 225 00:10:54,640 --> 00:10:58,280 Speaker 2: line from Hong Kong. Shuley's been writing about how China's 226 00:10:58,280 --> 00:11:02,400 Speaker 2: biotech industry is gaining momentum. Surely it's always a pleasure. 227 00:11:02,440 --> 00:11:05,839 Speaker 2: Can we begin by having you give me a sense 228 00:11:05,880 --> 00:11:10,000 Speaker 2: of scale here, perhaps a few examples of how biotech 229 00:11:10,120 --> 00:11:11,520 Speaker 2: in China is advancing. 230 00:11:12,400 --> 00:11:16,000 Speaker 5: Well. The revelation came really just a month ago when 231 00:11:16,080 --> 00:11:19,600 Speaker 5: Pisa agreed to pay a record one point two seven sorry, 232 00:11:20,440 --> 00:11:23,120 Speaker 5: when Pisa agreed to pay a record one point two 233 00:11:23,200 --> 00:11:27,480 Speaker 5: five billion upfront to license an experimental cancer drug from 234 00:11:27,559 --> 00:11:31,280 Speaker 5: a Chinese company costs three is bio. Two weeks later, 235 00:11:32,480 --> 00:11:36,840 Speaker 5: Bristol biosquib said it will pay Biointech another one point 236 00:11:36,880 --> 00:11:40,240 Speaker 5: five billion to license a similar cancer drug, and that 237 00:11:40,400 --> 00:11:45,880 Speaker 5: cancer drug was an acquisition from Biointech. That cancer drug 238 00:11:46,160 --> 00:11:49,920 Speaker 5: was bought by Buyotech from a Chinese company just lay 239 00:11:50,040 --> 00:11:52,880 Speaker 5: last year for eight hundred million. So what we're seeing 240 00:11:53,120 --> 00:11:56,360 Speaker 5: is that the Big Farmer are paying billions of dollars 241 00:11:56,400 --> 00:11:57,880 Speaker 5: licensing Chinese drugs. 242 00:11:58,160 --> 00:12:01,280 Speaker 2: It's interesting because when we think about our official intelligence, 243 00:12:01,320 --> 00:12:04,880 Speaker 2: obviously military defense, I think these are areas where the 244 00:12:04,920 --> 00:12:07,800 Speaker 2: government is kind of working with the private sector to 245 00:12:07,880 --> 00:12:12,760 Speaker 2: accelerate a lot of development. Is the same true in biotechnology? 246 00:12:12,920 --> 00:12:14,640 Speaker 2: Is the government involved in some way? 247 00:12:15,559 --> 00:12:19,319 Speaker 5: Not really? I mean, biotech is having a winter globally, 248 00:12:19,440 --> 00:12:22,360 Speaker 5: right like. What we are seeing is that the biotech 249 00:12:22,400 --> 00:12:25,240 Speaker 5: companies in the US are not getting that much to 250 00:12:25,320 --> 00:12:29,200 Speaker 5: venture capital funding. And the situation is even dar in China. 251 00:12:29,320 --> 00:12:32,640 Speaker 5: I mean, venture capital has lost its shine since the 252 00:12:32,679 --> 00:12:37,040 Speaker 5: government crackdown on big tech starting twenty twenty one. And 253 00:12:37,400 --> 00:12:41,480 Speaker 5: what we are seeing is that the biotech startups are 254 00:12:41,520 --> 00:12:45,040 Speaker 5: basically coming up with innovative drugs on their own. 255 00:12:45,400 --> 00:12:48,000 Speaker 2: So are we to understand then that this pace of 256 00:12:48,040 --> 00:12:51,319 Speaker 2: deal making and a lot of the appetite for biotech 257 00:12:51,320 --> 00:12:53,280 Speaker 2: in China is going to last? Is it durable? Do 258 00:12:53,320 --> 00:12:53,680 Speaker 2: you think? 259 00:12:54,520 --> 00:12:59,160 Speaker 5: I think so? And I think President Donald Trump's unpredictable 260 00:12:59,200 --> 00:13:02,640 Speaker 5: economic policy plays a huge catalyst. I mean, look at 261 00:13:02,679 --> 00:13:06,640 Speaker 5: Big Farmer. Trump has talked about cutting a prescription drug 262 00:13:06,679 --> 00:13:10,360 Speaker 5: prices by fifty nine percent at the minimum right, and 263 00:13:10,440 --> 00:13:14,440 Speaker 5: his big beautiful tax and spending bill has Medicare and 264 00:13:14,600 --> 00:13:18,000 Speaker 5: Medicaid cuts. What that means is that big farmer are 265 00:13:18,080 --> 00:13:20,680 Speaker 5: just not going to be as profitable as before, and 266 00:13:20,760 --> 00:13:25,360 Speaker 5: that gives them incentive to outsource research and development to 267 00:13:25,920 --> 00:13:28,240 Speaker 5: cheaper destinations such as China. 268 00:13:28,320 --> 00:13:31,840 Speaker 2: So within China, give me a sense of how the 269 00:13:31,920 --> 00:13:36,480 Speaker 2: labor market is supporting the biotech industry. Are young college 270 00:13:36,520 --> 00:13:38,360 Speaker 2: grads moving into the field, are their. 271 00:13:38,320 --> 00:13:42,440 Speaker 5: Opportunities absolutely In China, there is this popular phrase called 272 00:13:42,440 --> 00:13:45,880 Speaker 5: the engineer difend, and basically it talks about in the 273 00:13:45,960 --> 00:13:49,040 Speaker 5: last decade or so, China has been producing a ton 274 00:13:49,240 --> 00:13:56,439 Speaker 5: millions of the stem science students, for instance, like engineering 275 00:13:56,760 --> 00:14:02,120 Speaker 5: medicine are two of the most popular degrees for graduate 276 00:14:02,120 --> 00:14:07,000 Speaker 5: school studies. And all these young and fresh engineers, bioengineers, 277 00:14:07,040 --> 00:14:10,280 Speaker 5: medical students, they're coming to market right and they are 278 00:14:10,320 --> 00:14:13,880 Speaker 5: going to come to work for biotech startups for pretty 279 00:14:13,960 --> 00:14:15,679 Speaker 5: cheap prices compared to the US. 280 00:14:15,880 --> 00:14:17,400 Speaker 2: When you look at the way in which some of 281 00:14:17,440 --> 00:14:20,920 Speaker 2: these stocks have been performing, perhaps on the mainland or 282 00:14:20,920 --> 00:14:23,680 Speaker 2: in Hong Kong, have they been doing remarkably. 283 00:14:23,120 --> 00:14:27,640 Speaker 5: Well, remarkably well The hands in bioteching deck is up 284 00:14:27,720 --> 00:14:31,920 Speaker 5: sixty percent this year. By comparison, SMP biotech in Decks 285 00:14:32,000 --> 00:14:35,760 Speaker 5: is in the red right. And what investors are banking 286 00:14:35,800 --> 00:14:39,360 Speaker 5: on is that the Big farmer are not only going 287 00:14:39,400 --> 00:14:43,760 Speaker 5: to license billion dollar deals, they're also going to buy 288 00:14:43,800 --> 00:14:48,120 Speaker 5: equity stakes in those biotech smaller biotech companies. For instance, 289 00:14:48,240 --> 00:14:50,920 Speaker 5: the Pisor deal one point two five billion, like a 290 00:14:51,000 --> 00:14:54,720 Speaker 5: licensing deal with the three Spile, they're also putting a 291 00:14:54,800 --> 00:14:59,520 Speaker 5: one hundred million dollar dollar investment equity investment in the 292 00:14:59,600 --> 00:15:00,440 Speaker 5: Chinese company. 293 00:15:00,600 --> 00:15:03,360 Speaker 2: When I think about R and D drug development in 294 00:15:03,400 --> 00:15:06,880 Speaker 2: this country, I think about the Food and Drug Administration. 295 00:15:07,400 --> 00:15:11,560 Speaker 2: What is the regulatory regime like in China? And if 296 00:15:11,600 --> 00:15:16,360 Speaker 2: you had to compare let's say Chinese standards versus US standards, 297 00:15:16,400 --> 00:15:18,040 Speaker 2: what conclusion would you arrive at. 298 00:15:18,840 --> 00:15:23,840 Speaker 5: I think the Chinese are also quite strict with approving 299 00:15:24,080 --> 00:15:29,920 Speaker 5: drug use, and the Chinese regulatory body is actually pretty 300 00:15:30,280 --> 00:15:34,520 Speaker 5: open minded about introducing Western drugs because they do see 301 00:15:34,520 --> 00:15:38,760 Speaker 5: that Western drugs are often seen as better quality. So 302 00:15:38,840 --> 00:15:41,680 Speaker 5: in a way, for the Chinese biotech companies to go 303 00:15:41,760 --> 00:15:44,880 Speaker 5: to market, it could be just a little bit better 304 00:15:44,960 --> 00:15:48,720 Speaker 5: for them to partner up with the US Big farmer surely. 305 00:15:48,520 --> 00:15:50,360 Speaker 2: We'll leave it there. It's always a pleasure. Thank you 306 00:15:50,400 --> 00:15:54,400 Speaker 2: so much, Bloomberg opinion columnist July Wren. She's writing about 307 00:15:54,440 --> 00:15:57,640 Speaker 2: how China's biotech industry is gaining momentum. And you can 308 00:15:57,680 --> 00:16:00,240 Speaker 2: read Chuly's writing if you have a Bloomberg terminal. The 309 00:16:00,280 --> 00:16:03,680 Speaker 2: function is OPI N go shu Ley Wrenn joining us 310 00:16:03,680 --> 00:16:09,600 Speaker 2: here on the Daybreak Asia Podcast. Thanks for listening to 311 00:16:09,600 --> 00:16:14,560 Speaker 2: today's episode of the Bloomberg Daybreak Asia Edition podcast. Each weekday, 312 00:16:14,600 --> 00:16:18,520 Speaker 2: we look at the story shaping markets, finance, and geopolitics 313 00:16:18,520 --> 00:16:21,800 Speaker 2: in the Asia Pacific. You can find us on Apple, Spotify, 314 00:16:21,960 --> 00:16:25,440 Speaker 2: the Bloomberg Podcast YouTube channel, or anywhere else you listen. 315 00:16:25,880 --> 00:16:28,760 Speaker 2: Join us again tomorrow for insight on the market moves 316 00:16:28,840 --> 00:16:33,360 Speaker 2: from Hong Kong to Singapore and Australia. I'm Doug Chrisner, 317 00:16:33,520 --> 00:16:34,920 Speaker 2: and this is Bloomberg